Skip to main content

People in the News: Dan Calvo, Erik Wallden

Premium

Gyros has appointed Dan Calvo to serve as president and CEO. He replaces Erik Walldén, who had served in the same roles since 2009.

Calvo previously served as president and CEO of Oncoimmune USA. He held the same positions at Assay Designs and Cellomics. Oncoimmune USA, Assay Designs, and Cellomics have since been acquired by Health Discovery Lab, Enzo Biochem, and Thermo Fisher, respectively.

Uppsala, Sweden-based Gyros sells a microfluidics-based platform for performing immunoassays.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.